ID: ALA3038257

Max Phase: Preclinical

Molecular Formula: C16H23N5Na2O15P2

Molecular Weight: 589.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1O[C@H](OP(=O)([O-])OP(=O)([O-])OC[C@H]2O[C@@H](n3cnc4c(O)nc(N)nc43)[C@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O.[Na+].[Na+]

Standard InChI:  InChI=1S/C16H25N5O15P2.2Na/c1-4-7(22)9(24)11(26)15(33-4)35-38(30,31)36-37(28,29)32-2-5-8(23)10(25)14(34-5)21-3-18-6-12(21)19-16(17)20-13(6)27;;/h3-5,7-11,14-15,22-26H,2H2,1H3,(H,28,29)(H,30,31)(H3,17,19,20,27);;/q;2*+1/p-2/t4-,5+,7+,8+,9-,10+,11+,14+,15+;;/m0../s1

Standard InChI Key:  BUWGXAMQXMUESR-ZHRPCOANSA-L

Associated Targets(Human)

Galactoside 3(4)-L-fucosyltransferase 5 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Fucosyltransferase 6 19 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 589.34Molecular Weight (Monoisotopic): 589.0822AlogP: -3.19#Rotatable Bonds: 8
Polar Surface Area: 311.75Molecular Species: ACIDHBA: 18HBD: 9
#RO5 Violations: 3HBA (Lipinski): 20HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.73CX Basic pKa: 0.88CX LogP: -3.57CX LogD: -8.00
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.14Np Likeness Score: 1.28

References

1. Baisch G, Ohrlein R, Katopodis A.  (1996)  Enzymatic fucosylations with purine-diphosphate-fucoses (PDP-Fucoses),  (24): [10.1016/S0960-894X(96)00543-4]

Source